PHYSIDIA, founded in 2011 in Angers, France, specializes in home dialysis, prioritizing innovation to restore comfort and freedom for home patients. The company's S3 monitor, developed in collaboration with medical and para-medical experts, is dedicated to ensuring performance and safety in daily hemodialysis. It is portable, user-friendly, secure, and discreet in appearance, designed based on insights from engineers, healthcare professionals, and patients.
PHYSIDIA's ambition is to empower patients to manage their home dialysis independently and safely, adapting treatment to their lifestyle and preferences. The company's mission is a personal human adventure for its employees, aiming to meet the comfort and freedom needs of end-stage renal disease (ESRD) patients.
PHYSIDIA presents a compelling opportunity for investors with its innovative approach to home dialysis. As a manufacturer in the healthcare industry, it addresses a critical need while prioritizing patient autonomy and safety. With the potential to revolutionize home dialysis, PHYSIDIA offers a promising investment prospect in medical technology and patient-centered care.